Journey Medical (DERM) EBIAT: 2020-2025
Historic EBIAT for Journey Medical (DERM) over the last 5 years, with Sep 2025 value amounting to -$2.3 million.
- Journey Medical's EBIAT rose 3.14% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.7 million, marking a year-over-year increase of 52.75%. This contributed to the annual value of -$14.7 million for FY2024, which is 280.79% down from last year.
- According to the latest figures from Q3 2025, Journey Medical's EBIAT is -$2.3 million, which was up 39.01% from -$3.8 million recorded in Q2 2025.
- Journey Medical's 5-year EBIAT high stood at $16.8 million for Q3 2023, and its period low was -$21.8 million during Q4 2021.
- Moreover, its 3-year median value for EBIAT was -$3.4 million (2024), whereas its average is -$2.6 million.
- As far as peak fluctuations go, Journey Medical's EBIAT plummeted by 36,810.34% in 2021, and later skyrocketed by 266.56% in 2023.
- Over the past 5 years, Journey Medical's EBIAT (Quarterly) stood at -$21.8 million in 2021, then surged by 51.07% to -$10.6 million in 2022, then surged by 79.86% to -$2.1 million in 2023, then surged by 170.98% to $1.5 million in 2024, then rose by 3.14% to -$2.3 million in 2025.
- Its last three reported values are -$2.3 million in Q3 2025, -$3.8 million for Q2 2025, and -$4.1 million during Q1 2025.